drug

Persistence Targeted Smoking Cessation in SMI (PTSC-S)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Rutgers, The State University of New Jersey
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)
NCT03873337—Completed

KOLs & investigators

1
Marc L. Steinberg, PH.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Rutgers, The State University of New Jersey
company
trial
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)
NA
trial
indication
Schizophrenia
indication
Tobacco Use Disorder
indication
Tobacco Use Cessation
indication
Smoking Cessation
indication
KOL
Marc L. Steinberg, PH.D.
KOL score 5
person